Jonathan Isaacsohn
Chief Executive Officer
Pharmaceuticals
Cintas
Israel
Biography
most recently served as Teva’s Chief Medical Officer and was responsible for developing and overseeing the New Therapeutic Entities (NTEs) initiative across all therapeutic areas. During his career, Jon has been involved in developing hundreds of drugs from protocol design to global submission in various therapeutic areas, including cardio-metabolic, CNS, GI, oncology and infectious disease. Prior to joining Teva, Jon served as Executive Vice President, Head of Medical & Regulatory at Medpace, a global leader in research-based drug and device development. He trained in Internal Medicine and Cardiology at Harvard Medical School and was a member of the cardiology faculty at Yale Medical School. Jon is also a co-founder of the Metabolic & Atherosclerosis Research Center in Cincinnati, US.
Research Interest
Metabolic & Atherosclerosis Research
